Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesEpithelial–mesenchymal transition in ovarian cancer
Cancer Letters, 11/05/09
Vergara D et al. – EMT is believed to be governed by signals from the neoplastic microenvironment including a variety of cytokines and growth factors. In ovarian cancer EMT is induced by transforming growth factor–beta (TGF–beta), epidermal growth factor (EGF), hepatocyte growth factor (HGF) and endothelin–1 (ET–1). Alterations in these cellular pathways candidate them as useful target for ovarian cancer treatment.
Related Articles
Preventing future cancers by testing women with ovarian cancer for brca mutations
Journal of Clinical Oncology, 10/22/09
Relevance Score: 72%
Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
British Journal of Cancer, 11/02/09
Relevance Score: 70%
Unusual Metals Could Forge New Cancer Drug
ScienceDaily, 10/20/09
Relevance Score: 70%
New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09
Relevance Score: 70%
New drug aims to seek and destroy many types of cancer
EurekAlert, 10/06/09
Relevance Score: 70%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer
Oncogene, 03/22/10
Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression
Oncogene, 03/22/10
ETV6/RUNX1 abrogates mitotic checkpoint function and targets its key player MAD2L1
Oncogene, 03/22/10
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical Presentation and Outcome of Pediatric Ovarian Germ Cell Tumor: A Study of 40 Patients
Journal of Pediatric Hematology/Oncology, 03/22/10
Biweekly vinorelbine and gemcitabine as second-line and beyond treatment in ovarian cancer
Cancer Chemotherapy and Pharmacology, 03/22/10
Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells
Laboratory Investigation, 03/22/10
Sponsor
Article Search
Sponsor
Sponsor